![]() |
市场调查报告书
商品编码
1499544
医疗保健契约製造市场:按製造类型、最终用户划分 - 2024-2030 年全球预测Healthcare Contract Manufacturing Market by Manufacturing Type (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing), End-Users (Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年医疗保健契约製造市场规模为1,860亿美元,预计2024年将达2016.8亿美元,2030年将达3,292.2亿美元,复合年增长率为8.49%。
医疗保健契约製造市场由向其他医疗保健组织提供各种服务的公司组成,从药物处方和市场开拓到製造医疗保健设备和组件。这个市场允许医疗保健公司外包部分业务,降低成本,提高灵活性,并利用先进的製造技术和专业知识。推动该市场成长的关键因素包括对学名药的需求增加、慢性病的流行、对先进医疗设备的需求以及新治疗方式的快速采用。然而,严格的监管合规性、各种国际标准以及在降低成本的同时保持高品质流程的压力是阻碍市场成长的主要阻碍因素。医疗保健契约製造市场的机会是由技术进步驱动的,例如设备製造中的 3D 列印、个人化医疗保健以及日益重要的监管合规性。此外,持续投资研发创新生技药品和医疗保健设备并适应不断发展的数位医疗保健格局可能会进一步加剧市场竞争。
主要市场统计 | |
---|---|
基准年[2023] | 1860亿美元 |
预测年份 [2024] | 2016.8亿美元 |
预测年份 [2030] | 3292.2亿美元 |
复合年增长率(%) | 8.49% |
区域洞察
由于其高度发达的医疗基础设施和严格的监管要求,美洲正在经历显着的市场成长。由于越来越注重降低医疗保健成本,北美地区对受託製造厂商(CMO) 的外包(尤其是药品和医疗保健设备)正在迅速增加。由于政府的大力支持以及学术界和工业界的合作,欧洲国家处于医疗保健研究和开发的前沿。公共和私营部门在个人化医疗、基因组学、数位健康解决方案和先进疗法等领域的投资不断增加,进一步支持了欧洲、中东和非洲医疗保健契约製造的成长。由于国内需求成长、成本优势和技术进步,中国、日本和印度的医疗保健契约製造正在显着增长。亚太地区正在成为医疗保健设备和药品的製造地,导致受託製造公司在亚太市场的策略扩张。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在医疗保健契约製造市场中的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对医疗保健契约製造市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该细分市场竞争力的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在医疗保健契约製造市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[190 Pages Report] The Healthcare Contract Manufacturing Market size was estimated at USD 186.00 billion in 2023 and expected to reach USD 201.68 billion in 2024, at a CAGR 8.49% to reach USD 329.22 billion by 2030.
The healthcare contract manufacturing market comprises firms that offer a range of services, from drug formulation and development to medical devices and components manufacturing for other healthcare organizations. This market enables healthcare companies to outsource certain aspects of their operations, which can lead to lowered costs, increased flexibility, and access to advanced manufacturing technologies and expertise. The major factors propelling the growth of the healthcare contract manufacturing market include the increasing demand for generic medicines, the rising prevalence of chronic diseases, the need for advanced medical devices, and the surge in the introduction of new therapeutic methodologies. However, stringent regulatory compliances, varying international standards, and the pressure of maintaining high-quality processes while reducing costs are the major restraining factors hindering market growth. The opportunities within the healthcare contract manufacturing market are driven by technological advancements such as 3D printing in device manufacturing, personalized medicine, and the growing importance of regulatory compliance. Additionally, sustained investments in R&D for developing innovative biologics and medical devices and adapting to the evolving digital healthcare landscape could further enhance market competitiveness.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 186.00 billion |
Estimated Year [2024] | USD 201.68 billion |
Forecast Year [2030] | USD 329.22 billion |
CAGR (%) | 8.49% |
Regional Insights
The Americas has significant market growth due to highly developed healthcare infrastructure and stringent regulatory requirements in the region. The increased focus on bringing down healthcare costs has led to a surge in outsourcing to contract manufacturing organizations (CMOs), particularly for pharmaceuticals and medical devices in the North American region. European Countries are at the forefront of healthcare research and development, bolstered by strong government support and collaborations between academia and industry. The growing investments from the public and private sectors in areas such as personalized medicine, genomics, digital health solutions, and advanced therapies further drive the growth of healthcare contract manufacturing in the EMEA region. China, Japan, and India are witnessing significant growth in healthcare contract manufacturing due to rising domestic demand, cost advantages, and technological advances. The Asia Pacific (APAC) region has emerged as a medical device and pharmaceutical manufacturing hub, leading to strategic business expansions by contract manufacturing organizations in the APAC market.
Market Insights
The market dynamics represent an ever-changing landscape of the Healthcare Contract Manufacturing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Healthcare Contract Manufacturing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Healthcare Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Biomerics Announces Merger with Precision Concepts Medical
Biomerics LLC, a major player in vertically integrated contract manufacturing in the interventional medical device sector, has announced its strategic merger with Precision Concepts Medical. This significant transaction encompasses the acquisition of Precision Concepts International's (PCI) medical business and Precision Concepts Group (PCG), headquartered in Winston-Salem, North Carolina. This merger between Biomerics LLC and Precision Concepts Medical strengthened their presence in the healthcare contract manufacturing landscape. [Published On: 2023-05-17]
PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site
PCI Pharma Services, a biopharmaceutical contract manufacturing organization, recently announced its plans for a significant USD 50 million expansion at its Rockford, Illinois-based sterile injectables facility. The project is expected to involve the construction of a state-of-the-art 200,000-square-foot site that aims to substantially enhance the plant's production capacity for injectable drug-device combination products. The ambitious expansion initiative underscores PCI Pharma Services' commitment to addressing the growing demand for high-quality sterile injectable solutions while maintaining its position as a trusted and reliable partner in the biopharmaceutical sector. [Published On: 2023-03-16]
Medisurge and Signal Medical Announce Strategic Partnership
Medisurge, a healthcare contract manufacturing player, has announced its exclusive partnership with Signal Medical Corporation. Signal Medical has built a solid reputation for manufacturing high-quality knee and hip implants and providing advanced instrument systems to orthopedic surgeons. This strategic partnership between Medisurge and Signal Medical facilitates growth expansion for both companies in the competitive orthopedic market. By combining their expertise and resources, the partnership aims to establish an even stronger presence and provide enhanced services to clients within the industry. [Published On: 2023-01-25]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Healthcare Contract Manufacturing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Healthcare Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group, Almac Group, Baxter International, Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Curia Global, Inc., Evonik Industries AG, Famar Group, Jubilant Biosys Limited, Lonza Group Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare Private Limited, Recipharm AB, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage